Clinical trial · Interventional
Decision Making for Older Adults With Cancer
Improving Decision Making for Older Adults With Cancer: A Feasibility Pilot Study
NCT05374304CI-TRIAL-00085028completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a minimal risk, pilot cluster randomized controlled trial (CRT) to determine the feasibility and acceptability of training medical oncologists to use the Best Case/Worst Case-Geriatric Oncology (BC/WC-GeriOnc) communication tool in clinical practice with older adults with cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Lead-In (BC/WC-GeriOnc)
- description
- Lead-in phase oncologists will complete the BC/WC-GeriOnc communication tool training. Cancer treatment decision-making discussions will be recorded with 2 patients per oncologist and ask patients and oncologists to complete study questionnaires over one-month follow-up and one semi-structured interview about the decision-making process and communication.
- interventionNames
- Other: Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool
- type
- EXPERIMENTAL
- label
- Intervention (BC/WC-GeriOnc)
- description
- Intervention group oncologists will complete the BC/WC-GeriOnc communication tool training. Cancer treatment decision-making discussions will be recorded with 2 patients per oncologist to understand baseline oncologist practices and communication. Patients and oncologists will be asked to complete study questionnaires over a 2 month follow-up and 1 semi-structured interview. For each randomized oncologist, cancer treatment decision-making discussions will be recorded with 5 patients per oncologist. Both patients and oncologists will also be asked to complete study questionnaires over a 2 month follow-up and 1 semi-structured interview about the decision-making process and communication. Each patient will be given the option to select 1 caregiver to participate. Caregivers will be asked to complete study questionnaires and a semi-structured interview about their decision-making experience.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria for Oncologists: 1. Independently practicing medical oncology physician (non-ACGME oncology fellows who practice independently are eligible). 2. Annually care for at least 10 patients age \>=65 years with solid tumor malignancies in the outpatient setting (this criterion will be confirmed by oncologist report). 3. Willing to complete the two-hour intervention training. 4. At the time of enrollment, plans to continue outpatient practice at a University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC) affiliated site for the duration of the pilot study. Inclusion Criteria for Patients: 1. Age \>= 65 years. 2. Diagnosed with a solid tumor malignancy of any stage. 3. 3\. Upcoming decision-making discussion (in-person or via video conferencing) with a participating medical oncologist. 4. Able to read, write, and understand English. 5. Able to understand and provide written, informed consent. Adequate decisional capacity to consent for this study will be determined using the UCSF Decision-Making Capacity Assessment Tool. Patients with mild cognitive impairment who have adequate decisional capacity to consent for this study will be included. There are no performance status, organ function, or comorbidity eligibility criteria for this study. During the CRT phase, patients will be given the option to select a caregiver to participate in the study (not required). Caregivers cannot participate without an enrolled patient. Caregivers may be a family member, partner, or friend of the participating patient. Inclusion Criteria for Caregivers: 1. Age \>=18 years. 2. Must plan to be present during the medical oncology decision-making discussion and follow-up visits within the first 3 months. 3. Able to read, write, and understand English. 4. Able to understand and provide written, informed consent. Exclusion Criteria: Exclusion Criteria for Oncologists: 1\. Medical oncologists who practice solely in the inpatient setting are not eligible. Exclusion Criteria for Patients: 1. Plan for UCSF second opinion evaluation only. Patients are eligible if they plan to transfer care to UCSF at the time of enrollment. 2. Planned decision-making discussion via phone only (without video). 3. Patients participating in another cancer communication/decision support intervention study with their medical oncologist.
References
Publications (0)
Data not yet available
No reference posted for this study.